SELANK 10MG

Selank is a synthetic heptapeptide analog of tuftsin with demonstrated anxiolytic and anti-asthenic (energy-boosting) properties in human clinical trials. In Russian studies, Selank produced anxiolytic effects comparable to benzodiazepines without sedation or dependence potential.

15 CLICKS = 500MCG

Selank is a synthetic analog of the immunomodulatory peptide tuftsin, consisting of the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. In Russian clinical trials for anxiety disorders and neurasthenia, Selank produced anxiolytic effects comparable to benzodiazepines while also providing anti-asthenic (energy-boosting) benefits without sedative side effects or dependence potential. Preclinical studies demonstrated that Selank eliminated fear and anxiety behaviors with long-term stabilizing effects on neurobehavior. Studies confirmed robust anxiolytic efficacy comparable to classical tranquilizers. While most published human data utilized intranasal dosing (the original formulation), subcutaneous administration has shown effectiveness in research settings with consistent absorption and ease of dose measurement.

Goal : Support reduction of anxiety and neurasthenia symptoms while providing anti-asthenic (energy-boosting) benefits.

Schedule : Daily subcutaneous injections for 4-week cycles with 4-week breaks (8–16 weeks total protocol).

Dose Range : 300–500 mcg daily with gradual titration.

Dosing Protocol :
Suggested daily titration approach.

• Start : 300mcg daily for weeks 1–2; clinicians treating cognitive or anxiety issues often begin at this level.
• Target : 500mcg daily by weeks 3–4 if lower doses are well-tolerated.
• Frequency : Once per day (subcutaneous); some protocols use 5 days per week with 2-day breaks.
• Cycle Pattern : 4 weeks on, 4 weeks off to prevent tachyphylaxis; repeat as needed.
• Timing : Any consistent time; rotate injection sites to prevent irritation.